Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/193.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Conjugate or complex
Description: Subject matter involving a conjugate or a complex.

Sub-classes under this class:

Class Number Class Name Patents
424/197.11 Conjugate or complex includes bacterium or component thereof or substance produced by said bacterium 474
424/195.11 Conjugate or complex includes hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or fragment thereof 273
424/196.11 Conjugate or complex includes virus or componenet thereof 295
424/194.1 Conjugated via claimed linking group, bond, or coupling agent 462

Patents under this class:

Patent Number Title Of Patent Date Issued
8709713 Viruses lacking epithelial cell receptor entry Apr. 29, 2014
8703702 Therapeutically active .alpha.-MSH analogues Apr. 22, 2014
8685404 Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction Apr. 1, 2014
8679506 Glucan-based vaccines Mar. 25, 2014
8673293 Use of modified cells for the treatment of multiple sclerosis Mar. 18, 2014
8669355 Vaccine Mar. 11, 2014
8663651 T-140 peptide analogs having CXCR4 super-agonist activity for immunomodulation Mar. 4, 2014
8663650 Methods and compositions comprising supramolecular constructs Mar. 4, 2014
8663644 Augmentation of titer for vaccination in animals Mar. 4, 2014
8658179 Glycosylated specificity exchangers Feb. 25, 2014
8658178 Carbon nanotube compositions and methods of use thereof Feb. 25, 2014
8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cells Feb. 18, 2014
8652484 Delivery system for cytotoxic drugs by bispecific antibody pretargeting Feb. 18, 2014
8642651 Methods and compositions for improved chromium complexes Feb. 4, 2014
8642044 Prevention and treatment of amyloidogenic disease Feb. 4, 2014
8623378 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof Jan. 7, 2014
8617566 Composition comprising VLP and amyloid beta peptide Dec. 31, 2013
8617532 Therapeutic use of interferon-polymer conjugates Dec. 31, 2013
8604127 Conjugate of catechol-modified polyethylene glycol with protein or peptide and preparation method thereof Dec. 10, 2013
8603484 Multivalent pneumococcal polysaccharide-protein conjugate composition Dec. 10, 2013
8603458 Genetic adjuvants for immunotherapy Dec. 10, 2013
8597660 Therapeutic approach to neurodegenerative disorders using a TFP5-peptide Dec. 3, 2013
8597659 Tetrameric cytokines with improved biological activity Dec. 3, 2013
8591910 Chemically programmable immunity Nov. 26, 2013
8591890 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality Nov. 26, 2013
8580274 Drug transporter, and adjuvant and vaccine each utilizing same Nov. 12, 2013
8574577 VEGF antibodies comprising modular recognition domains Nov. 5, 2013
8568989 Peptides and methods for the detection of Lyme disease antibodies Oct. 29, 2013
8563508 Method for preventing or reducing acute renal failure by administration of therapeutically active .alpha.-MSH analogues Oct. 22, 2013
8563006 Immunogenic compositions for the prevention and treatment of meningococcal disease Oct. 22, 2013
8562999 Formulations which stabilize and inhibit precipitation of immunogenic compositions Oct. 22, 2013
8562988 Strategies for improved cancer vaccines Oct. 22, 2013
8557250 Methods for preparing complex multivalent immunogenic conjugates Oct. 15, 2013
8557243 EFGR antibodies comprising modular recognition domains Oct. 15, 2013
8557242 ERBB2 antibodies comprising modular recognition domains Oct. 15, 2013
8551527 Process for stabilizing an adjuvant containing vaccine composition Oct. 8, 2013
8551480 Compositions and methods of use of immunotoxins comprising ranpirnase (Rap) show potent cytotoxic activity Oct. 8, 2013
8541203 Activatable binding polypeptides and methods of identification and use thereof Sep. 24, 2013
8540964 Polyvalent conjugate vaccine for cancer Sep. 24, 2013
8535942 Glypican-3 (GPC3)-derived tumor rejection antigenic peptides useful for HLA-A2-positive patients and pharmaceutical comprising the same Sep. 17, 2013
8535681 Sustained drug delivery system Sep. 17, 2013
8530189 Sustained drug delivery system Sep. 10, 2013
8529912 Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof Sep. 10, 2013
8524860 Peptides with capacity to bind to scurfin and applications Sep. 3, 2013
8524244 Targeted therapeutics based on engineered proteins that bind EGFR Sep. 3, 2013
8513392 Conjugation of streptococcal capsular saccharides Aug. 20, 2013
8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions Aug. 20, 2013
8512708 GP96 derived peptides Aug. 20, 2013
8506971 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria Aug. 13, 2013
8501197 Compositions and methods for stimulating immune response against Moraxella catarrhalis Aug. 6, 2013

  Recently Added Patents
Controller interface providing improved data reliability
Liquid dispensing apparatus
Capacitance sensing
Method for counting and segmenting viral particles in an image
Retransmission and retransmission request in data communication systems
Methods and apparatus for ultrasonic cleaning
Battery pack with connecting device
  Randomly Featured Patents
Electrical connection structure, production method thereof, and electric wiring method
Fractal coding of data
Systems and methods for dynamic authentication using physical keys
Implementation of functions of multiple successive bits of a shift register
Evaporated fuel processing apparatus for internal combustion engine and method
Method for performing a brake pipe leakage test
Pre-treatment tunnel and method of preparing extrusions or section bars for being powder or liquid coated
Device for heating and cooling a beverage
Poly(ethylene terephthalate) (PET) copolymers containing both 1,4-cyclohexanedimethanol and isophthalic acid moieties
Training a user on an accessiblity device